← 產業報告目錄
Drug-coated Balloon (DCB) Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-08-03頁數 134報告編號 APO-3877361419
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
The global Drug-coated Balloon (DCB) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drug-coated Balloon (DCB) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Drug-coated Balloon (DCB) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drug-coated Balloon (DCB) include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug-coated Balloon (DCB) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug-coated Balloon (DCB) Market by Company
Medtronic
Boston Scientific
Becton Dickinson
Biotronik
B. Braun
Philips
Abbott
Eurocor
Yinyi Biotech
Lepu Medical
Grand Pharma
Acotec Scientific
Shenqi Medical
MicroPort
Zylox-Tonbridge Medical
Zhejiang Barty Medical
Drug-coated Balloon (DCB) Segment by Type
Coronary DCB
Peripheral DCB (FP)
Peripheral DCB (BTK)
Drug-coated Balloon (DCB) Segment by Application
Dialysis Access (AVF/AVG)
Femoropopliteal (FP)
Below-the-Knee (BTK)
Drug-coated Balloon (DCB) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug-coated Balloon (DCB) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug-coated Balloon (DCB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Drug-coated Balloon (DCB) Market Size (2021-2032)
2.2.2 Global Drug-coated Balloon (DCB) Sales (2021-2032)
2.2.3 Global Drug-coated Balloon (DCB) Market Average Price (2021-2032)
2.3 Drug-coated Balloon (DCB) by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Coronary DCB
2.3.3 Peripheral DCB (FP)
2.3.4 Peripheral DCB (BTK)
2.4 Drug-coated Balloon (DCB) by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Dialysis Access (AVF/AVG)
2.4.3 Femoropopliteal (FP)
2.4.4 Below-the-Knee (BTK)
3 Market Competitive Landscape by Manufacturers
3.1 Global Drug-coated Balloon (DCB) Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Drug-coated Balloon (DCB) Sales (k units) of Manufacturers (2021-2026)
3.3 Global Drug-coated Balloon (DCB) Revenue of Manufacturers (2021-2026)
3.4 Global Drug-coated Balloon (DCB) Average Price by Manufacturers (2021-2026)
3.5 Global Drug-coated Balloon (DCB) Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Drug-coated Balloon (DCB), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Drug-coated Balloon (DCB), Product Type & Application
3.8 Global Manufacturers of Drug-coated Balloon (DCB), Established Date
3.9 Global Drug-coated Balloon (DCB) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Medtronic
4.1.1 Medtronic Company Information
4.1.2 Medtronic Business Overview
4.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
4.1.5 Medtronic Recent Developments
4.2 Boston Scientific
4.2.1 Boston Scientific Company Information
4.2.2 Boston Scientific Business Overview
4.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
4.2.5 Boston Scientific Recent Developments
4.3 Becton Dickinson
4.3.1 Becton Dickinson Company Information
4.3.2 Becton Dickinson Business Overview
4.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
4.3.5 Becton Dickinson Recent Developments
4.4 Biotronik
4.4.1 Biotronik Company Information
4.4.2 Biotronik Business Overview
4.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
4.4.5 Biotronik Recent Developments
4.5 B. Braun
4.5.1 B. Braun Company Information
4.5.2 B. Braun Business Overview
4.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
4.5.5 B. Braun Recent Developments
4.6 Philips
4.6.1 Philips Company Information
4.6.2 Philips Business Overview
4.6.3 Philips Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
4.6.5 Philips Recent Developments
4.7 Abbott
4.7.1 Abbott Company Information
4.7.2 Abbott Business Overview
4.7.3 Abbott Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
4.7.5 Abbott Recent Developments
4.8 Eurocor
4.8.1 Eurocor Company Information
4.8.2 Eurocor Business Overview
4.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
4.8.5 Eurocor Recent Developments
4.9 Yinyi Biotech
4.9.1 Yinyi Biotech Company Information
4.9.2 Yinyi Biotech Business Overview
4.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
4.9.5 Yinyi Biotech Recent Developments
4.10 Lepu Medical
4.10.1 Lepu Medical Company Information
4.10.2 Lepu Medical Business Overview
4.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
4.10.5 Lepu Medical Recent Developments
4.11 Grand Pharma
4.11.1 Grand Pharma Company Information
4.11.2 Grand Pharma Business Overview
4.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
4.11.5 Grand Pharma Recent Developments
4.12 Acotec Scientific
4.12.1 Acotec Scientific Company Information
4.12.2 Acotec Scientific Business Overview
4.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
4.12.5 Acotec Scientific Recent Developments
4.13 Shenqi Medical
4.13.1 Shenqi Medical Company Information
4.13.2 Shenqi Medical Business Overview
4.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
4.13.5 Shenqi Medical Recent Developments
4.14 MicroPort
4.14.1 MicroPort Company Information
4.14.2 MicroPort Business Overview
4.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
4.14.5 MicroPort Recent Developments
4.15 Zylox-Tonbridge Medical
4.15.1 Zylox-Tonbridge Medical Company Information
4.15.2 Zylox-Tonbridge Medical Business Overview
4.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
4.15.5 Zylox-Tonbridge Medical Recent Developments
4.16 Zhejiang Barty Medical
4.16.1 Zhejiang Barty Medical Company Information
4.16.2 Zhejiang Barty Medical Business Overview
4.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
4.16.5 Zhejiang Barty Medical Recent Developments
5 Global Drug-coated Balloon (DCB) Market Scenario by Region
5.1 Global Drug-coated Balloon (DCB) Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Drug-coated Balloon (DCB) Sales by Region: 2021-2032
5.2.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021-2026
5.2.2 Global Drug-coated Balloon (DCB) Sales by Region: 2027-2032
5.3 Global Drug-coated Balloon (DCB) Revenue by Region: 2021-2032
5.3.1 Global Drug-coated Balloon (DCB) Revenue by Region: 2021-2026
5.3.2 Global Drug-coated Balloon (DCB) Revenue by Region: 2027-2032
5.4 North America Drug-coated Balloon (DCB) Market Facts & Figures by Country
5.4.1 North America Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Drug-coated Balloon (DCB) Sales by Country (2021-2032)
5.4.3 North America Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Drug-coated Balloon (DCB) Market Facts & Figures by Country
5.5.1 Europe Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Drug-coated Balloon (DCB) Sales by Country (2021-2032)
5.5.3 Europe Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Drug-coated Balloon (DCB) Market Facts & Figures by Country
5.6.1 Asia Pacific Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2032)
5.6.3 Asia Pacific Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Drug-coated Balloon (DCB) Market Facts & Figures by Country
5.7.1 South America Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Drug-coated Balloon (DCB) Sales by Country (2021-2032)
5.7.3 South America Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Drug-coated Balloon (DCB) Market Facts & Figures by Country
5.8.1 Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2032)
5.8.3 Middle East and Africa Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032)
6.1.1 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032) & (k units)
6.1.2 Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032)
6.2 Global Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
6.2.1 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032)
6.3 Global Drug-coated Balloon (DCB) Price by Type (2021-2032)
7 Segment by Application
7.1 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032)
7.1.1 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032) & (k units)
7.1.2 Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032)
7.2 Global Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
7.2.1 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032)
7.3 Global Drug-coated Balloon (DCB) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Drug-coated Balloon (DCB) Value Chain Analysis
8.1.1 Drug-coated Balloon (DCB) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Drug-coated Balloon (DCB) Production Mode & Process
8.2 Drug-coated Balloon (DCB) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Drug-coated Balloon (DCB) Distributors
8.2.3 Drug-coated Balloon (DCB) Customers
9 Global Drug-coated Balloon (DCB) Analyzing Market Dynamics
9.1 Drug-coated Balloon (DCB) Industry Trends
9.2 Drug-coated Balloon (DCB) Industry Drivers
9.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
9.4 Drug-coated Balloon (DCB) Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Drug-coated Balloon (DCB) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Drug-coated Balloon (DCB) Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Drug-coated Balloon (DCB) Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Drug-coated Balloon (DCB) Revenue of Manufacturers (2021-2026)
Table 9. Global Drug-coated Balloon (DCB) Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Drug-coated Balloon (DCB) Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Drug-coated Balloon (DCB) Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Drug-coated Balloon (DCB), Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Drug-coated Balloon (DCB), Product Type & Application
Table 14. Global Drug-coated Balloon (DCB) Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Drug-coated Balloon (DCB) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Medtronic Company Information
Table 19. Medtronic Business Overview
Table 20. Medtronic Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Medtronic Drug-coated Balloon (DCB) Product Portfolio
Table 22. Medtronic Recent Developments
Table 23. Boston Scientific Company Information
Table 24. Boston Scientific Business Overview
Table 25. Boston Scientific Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
Table 27. Boston Scientific Recent Developments
Table 28. Becton Dickinson Company Information
Table 29. Becton Dickinson Business Overview
Table 30. Becton Dickinson Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
Table 32. Becton Dickinson Recent Developments
Table 33. Biotronik Company Information
Table 34. Biotronik Business Overview
Table 35. Biotronik Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Biotronik Drug-coated Balloon (DCB) Product Portfolio
Table 37. Biotronik Recent Developments
Table 38. B. Braun Company Information
Table 39. B. Braun Business Overview
Table 40. B. Braun Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. B. Braun Drug-coated Balloon (DCB) Product Portfolio
Table 42. B. Braun Recent Developments
Table 43. Philips Company Information
Table 44. Philips Business Overview
Table 45. Philips Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Philips Drug-coated Balloon (DCB) Product Portfolio
Table 47. Philips Recent Developments
Table 48. Abbott Company Information
Table 49. Abbott Business Overview
Table 50. Abbott Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Abbott Drug-coated Balloon (DCB) Product Portfolio
Table 52. Abbott Recent Developments
Table 53. Eurocor Company Information
Table 54. Eurocor Business Overview
Table 55. Eurocor Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Eurocor Drug-coated Balloon (DCB) Product Portfolio
Table 57. Eurocor Recent Developments
Table 58. Yinyi Biotech Company Information
Table 59. Yinyi Biotech Business Overview
Table 60. Yinyi Biotech Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
Table 62. Yinyi Biotech Recent Developments
Table 63. Lepu Medical Company Information
Table 64. Lepu Medical Business Overview
Table 65. Lepu Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
Table 67. Lepu Medical Recent Developments
Table 68. Grand Pharma Company Information
Table 69. Grand Pharma Business Overview
Table 70. Grand Pharma Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
Table 72. Grand Pharma Recent Developments
Table 73. Acotec Scientific Company Information
Table 74. Acotec Scientific Business Overview
Table 75. Acotec Scientific Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
Table 77. Acotec Scientific Recent Developments
Table 78. Shenqi Medical Company Information
Table 79. Shenqi Medical Business Overview
Table 80. Shenqi Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
Table 82. Shenqi Medical Recent Developments
Table 83. MicroPort Company Information
Table 84. MicroPort Business Overview
Table 85. MicroPort Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. MicroPort Drug-coated Balloon (DCB) Product Portfolio
Table 87. MicroPort Recent Developments
Table 88. Zylox-Tonbridge Medical Company Information
Table 89. Zylox-Tonbridge Medical Business Overview
Table 90. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
Table 92. Zylox-Tonbridge Medical Recent Developments
Table 93. Zhejiang Barty Medical Company Information
Table 94. Zhejiang Barty Medical Business Overview
Table 95. Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
Table 97. Zhejiang Barty Medical Recent Developments
Table 98. Global Drug-coated Balloon (DCB) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 99. Global Drug-coated Balloon (DCB) Sales by Region (2021-2026) & (k units)
Table 100. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2026)
Table 101. Global Drug-coated Balloon (DCB) Sales by Region (2027-2032) & (k units)
Table 102. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2027-2032)
Table 103. Global Drug-coated Balloon (DCB) Revenue by Region (2021-2026) & (US$ Million)
Table 104. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2026)
Table 105. Global Drug-coated Balloon (DCB) Revenue by Region (2027-2032) & (US$ Million)
Table 106. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2027-2032)
Table 107. North America Drug-coated Balloon (DCB) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. North America Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units)
Table 109. North America Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units)
Table 110. North America Drug-coated Balloon (DCB) Revenue by Country (2021-2026) & (US$ Million)
Table 111. North America Drug-coated Balloon (DCB) Revenue by Country (2027-2032) & (US$ Million)
Table 112. Europe Drug-coated Balloon (DCB) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Europe Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units)
Table 114. Europe Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units)
Table 115. Europe Drug-coated Balloon (DCB) Revenue by Country (2021-2026) & (US$ Million)
Table 116. Europe Drug-coated Balloon (DCB) Revenue by Country (2027-2032) & (US$ Million)
Table 117. Asia Pacific Drug-coated Balloon (DCB) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units)
Table 119. Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units)
Table 120. Asia Pacific Drug-coated Balloon (DCB) Revenue by Country (2021-2026) & (US$ Million)
Table 121. Asia Pacific Drug-coated Balloon (DCB) Revenue by Country (2027-2032) & (US$ Million)
Table 122. South America Drug-coated Balloon (DCB) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. South America Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units)
Table 124. South America Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units)
Table 125. South America Drug-coated Balloon (DCB) Revenue by Country (2021-2026) & (US$ Million)
Table 126. South America Drug-coated Balloon (DCB) Revenue by Country (2027-2032) & (US$ Million)
Table 127. Middle East and Africa Drug-coated Balloon (DCB) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units)
Table 129. Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units)
Table 130. Middle East and Africa Drug-coated Balloon (DCB) Revenue by Country (2021-2026) & (US$ Million)
Table 131. Middle East and Africa Drug-coated Balloon (DCB) Revenue by Country (2027-2032) & (US$ Million)
Table 132. Global Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units)
Table 133. Global Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units)
Table 134. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2026)
Table 135. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2027-2032)
Table 136. Global Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million)
Table 137. Global Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million)
Table 138. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2026)
Table 139. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2027-2032)
Table 140. Global Drug-coated Balloon (DCB) Price by Type (2021-2026) & (USD/unit)
Table 141. Global Drug-coated Balloon (DCB) Price by Type (2027-2032) & (USD/unit)
Table 142. Global Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units)
Table 143. Global Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units)
Table 144. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2026)
Table 145. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2027-2032)
Table 146. Global Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million)
Table 147. Global Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million)
Table 148. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2026)
Table 149. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2027-2032)
Table 150. Global Drug-coated Balloon (DCB) Price by Application (2021-2026) & (USD/unit)
Table 151. Global Drug-coated Balloon (DCB) Price by Application (2027-2032) & (USD/unit)
Table 152. Key Raw Materials
Table 153. Raw Materials Key Suppliers
Table 154. Drug-coated Balloon (DCB) Distributors List
Table 155. Drug-coated Balloon (DCB) Customers List
Table 156. Drug-coated Balloon (DCB) Industry Trends
Table 157. Drug-coated Balloon (DCB) Industry Drivers
Table 158. Drug-coated Balloon (DCB) Industry Restraints
Table 159. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug-coated Balloon (DCB) Product Image
Figure 5. Global Drug-coated Balloon (DCB) Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Drug-coated Balloon (DCB) Market Size (2021-2032) & (US$ Million)
Figure 7. Global Drug-coated Balloon (DCB) Sales (2021-2032) & (k units)
Figure 8. Global Drug-coated Balloon (DCB) Average Price (USD/unit) & (2021-2032)
Figure 9. Coronary DCB Product Image
Figure 10. Peripheral DCB (FP) Product Image
Figure 11. Peripheral DCB (BTK) Product Image
Figure 12. Dialysis Access (AVF/AVG) Product Image
Figure 13. Femoropopliteal (FP) Product Image
Figure 14. Below-the-Knee (BTK) Product Image
Figure 15. Global Drug-coated Balloon (DCB) Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Drug-coated Balloon (DCB), Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Drug-coated Balloon (DCB) Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Drug-coated Balloon (DCB) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Drug-coated Balloon (DCB) Sales by Region in 2025
Figure 21. Global Drug-coated Balloon (DCB) Revenue by Region in 2025
Figure 22. North America Drug-coated Balloon (DCB) Market Size by Country in 2025
Figure 23. North America Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032)
Figure 24. North America Drug-coated Balloon (DCB) Revenue Market Share by Country (2021-2032)
Figure 25. United States Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Drug-coated Balloon (DCB) Market Size by Country in 2025
Figure 29. Europe Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032)
Figure 30. Europe Drug-coated Balloon (DCB) Revenue Market Share by Country (2021-2032)
Figure 31. Germany Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Drug-coated Balloon (DCB) Market Size by Country in 2025
Figure 42. Asia Pacific Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Drug-coated Balloon (DCB) Revenue Market Share by Country (2021-2032)
Figure 44. China Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Drug-coated Balloon (DCB) Market Size by Country in 2025
Figure 53. South America Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032)
Figure 54. South America Drug-coated Balloon (DCB) Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country in 2025
Figure 59. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032)
Figure 60. Middle East and Africa Drug-coated Balloon (DCB) Revenue Market Share by Country (2021-2032)
Figure 61. Egypt Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. South Africa Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Israel Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Türkiye Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. GCC Countries Drug-coated Balloon (DCB) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032)
Figure 67. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032)
Figure 68. Global Drug-coated Balloon (DCB) Price (USD/unit) by Type (2021-2032)
Figure 69. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032)
Figure 70. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032)
Figure 71. Global Drug-coated Balloon (DCB) Price (USD/unit) by Application (2021-2032)
Figure 72. Drug-coated Balloon (DCB) Value Chain
Figure 73. Drug-coated Balloon (DCB) Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Drug-coated Balloon (DCB) Industry Opportunities and Challenges
提及公司
MedtronicBoston ScientificBecton DickinsonBiotronikB. BraunPhilipsAbbottEurocorYinyi BiotechLepu MedicalGrand PharmaAcotec ScientificShenqi MedicalMicroPortZylox-Tonbridge MedicalZhejiang Barty Medical
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們